Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...

This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

The FDA today issued an alert around a safety concern regarding diabetes devices that rely on smartphones to deliver critical ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Continuous glucose monitors are small devices that use a sensor under the skin to measure blood sugar, sending regular ...

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Fourteen-day continuous glucose monitoring (CGM) traces added to Diabetes Control and Complications Trial (DCCT) data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Devices and Getinge have recently announced their partnership under which they will integrate Getinge’s bioreactors with 908 ...

The US Food and Drug Administration (FDA) is cautioning patients and caregivers about the potential for not receiving blood ...

Glucotrack has cleared the first human clinical study of its long-term continuous glucose monitoring implant, designed to ...